Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentinel Cohort for REACT: AMG for MDRO Colonization
NCT05780801Phase 1Completed
- Sponsor
- Emory University
- Start
- Apr 2023
- Primary completion
- Jan 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Allogeneic Microbiota in Glycerol in organism colonization, sponsored by Emory University. Primary endpoints: Frequency of adverse events by MT administration at Day 7 and Severity of adverse events caused by administration for MT at Day 7. Started Apr 2023; status: completed.
02
Drugs
Allogeneic Microbiota in Glycerol
03
Conditions
organism colonization
Beyond the preview
Go deeper on NCT05780801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05780801.